Fragility of Randomized Clinical Trials Using Mesh in Abdominal Wall Reconstruction

This systematic review evaluates the fragility of randomized clinical trials that used mesh in abdominal wall reconstruction. eng from Becton Dickinson, WL Gore, AbbVie, and 3M during the conduct of the study and serving as a consultant for Integra LifeSciences, Baxter, WL Gore, Becton Dickinson, and Bard Pharmaceuticals outside the submitted work. Dr Smart reported receiving funding from the National Institute for Health and Care Research and receiving personal fees from Medtronic and WL Gore outside the submitted work. Dr Heniford reported receiving personal fees from WL Gore and Allergan outside the submitted work. No other disclosures were reported.UnknownThe article is available via Open Access. Click on the 'Additional link' above to access the full-text